Search Results - Mendivil, A.A.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Pegfilgrastim Safely Administered on the Same Day as Dose-dense Chemotherapy for Patients with Advanced-stage Ovarian Carcinoma

    Pegfilgrastim Safely Administered on the Same Day as Dose-dense Chemotherapy for Patients with Advanced-stage Ovarian Carcinoma by Micha, J.P, Brown, J.V, Rettenmaier, M.A, Abaid, L.N, Mendivil, A.A, Lopez, K.L, Goldstein, B.H

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Phase II VIRO-15 trial of olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588)

    Phase II VIRO-15 trial of olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588) by Holloway, R.W., Mendivil, A.A., Kendrick, J.E., Abaid, L.N., Brown, J.V., Fitzsimmons, C.K., Kennard, J.A., King, M.M., LeBlanc, J., Lopez, K., Manyam, M., McKenzie, N.D., Mori, K.M., Smith, J.L., Stephens, A.J., Ahmad, S.

    Published in Gynecologic oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    166P Impact of immunotherapy (IT) on overall survival (OS) of patients with malignant pleural mesothelioma (MPM) adjusted for tumor histology

    166P Impact of immunotherapy (IT) on overall survival (OS) of patients with malignant pleural mesothelioma (MPM) adjusted for tumor histology by Perez, S.M. Cedres, Valdivia, A.A., Pastrana, J.D. Assaf, Gomez, P. Iranzo, Aranda, N. Pardo, Mendivil, A.F. Navarro, Martinez-Marti, A., Prina, M. Meazza, Garcia-Galea, E., Gonzalo, J., Dienstmann, R., Felip, E.

    Published in ESMO open
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: